Analysis of proteome changes additionally allows for understatingthe interactions of cellular metabolic pathways and their implicationin in vitro tumor modeling, especially when theirup- or downregulation is associated with other molecular markers.For this purpose, we first examined the CD44, MCAM, and vimentin simultaneousexpression in both of the tested melanomas. This evidence concerns the gene MCAM and neoplasm.